Avoiding deceptive imprinting of the immune response to HIV-1 infection in vaccine development

International Reviews of Immunology

Volumn 23, Issue 5-6, 2004, Pages 423-436

  Muller, Sybille ^a  

^a Immpheron Incorporated   (United States)

Author keywords

AIDS vaccine; Anti idiotypic antibodies; Clonal restriction; HIV 1 infection; Lymphocyte; Original antigenic sin; Pediatric AIDS

Indexed keywords

ANTIIDIOTYPIC ANTIBODY; EPITOPE; HIV 1 TAT TOXOID; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; IDIOTYPE BASED HUMAN IMMUNODEFICIENCY VIRUS VACCINE; MONOCLONAL ANTIBODY 1F7; MONOCLONAL ANTIBODY MAB4; PARASITE ANTIGEN; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG; VIRUS ANTIGEN;

ANTIBODY RESPONSE; B LYMPHOCYTE; CHILDHOOD DISEASE; CLONAL RESTRICTION; DECEPTIVE IMPRINTING; DRUG DESIGN; GENETIC VARIABILITY; HOST RESISTANCE; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNITY; IMMUNOLOGICAL MEMORY; IMMUNOLOGICAL PRIMING; IMMUNOTHERAPY; LYMPHOCYTE; MOLECULAR IMPRINTING; NONHUMAN; ORIGINAL ANTIGENIC SIN; PRIORITY JOURNAL; QUASISPECIES; REVIEW; SPECIES; T LYMPHOCYTE; VACCINE DESIGN; VACCINE PRODUCTION; VARIANT VIRUS; VERTICAL TRANSMISSION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AIDS VACCINES; GENE PRODUCTS, TAT; HIV ENVELOPE PROTEIN GP120; HIV-1; HUMANS; IMMUNODOMINANT EPITOPES;

EID: 4644285658     PISSN: 08830185     EISSN: None     Source Type: Journal    
DOI: 10.1080/08830180490432802     Document Type: Review

References (53)

1. T. Francis, Jr., Influenza: New aquaintenance, Ann. Intern. Med., 39: 203-221, 1953.
2. A. Amadori, R. Zamarchi, V. Ciminale, A. Del Mistro, S. Siervo, A. Alberti, M. Colombatti, and L. Chieco-Bianchi, HIV-1-specific B cell activation: A major constituent of spontaneous B cell activation during HIV-1 infection, J. Immunol., 143: 2146-2152, 1989.
3. L.M.E. Grimaldi, R.P. Roos, S.G. DeVar, W.G. Robey, J.M. Casey, M.E. Geerney, Apatoff, B.R. and A. Lazzarins, Restricted heterogeneity of antibody to gp120 and p24 in AIDS, J. Immunol., 141: 114-117, 1988.
4. S. Müller, H. Wang, G.J. Silverman, G. Bramlet, N. Haigwood, and H. Kohler, B-cell abnormalities in AIDS: Stable and clonally-restricted antibody response in HIV-1 infection, Scand. J. Immunol., 38: 327-334, 1993.
5. S. Müller, P.L. Nara, R. D'Amelio, R. Biselli, D. Gold, H. Wang, H. Kohler, and Silverman, G.J. Clonal patterns in the human immune response to HIV-1 infection, Internat. Rev. of Immunol., 9: 1-13, 1992.
6. R.R. D'Amelio, R. Biselli, P.M. Nisini, A. Matricardi, I. Aiuti, E. Mezzaroma, O. Pinter, N. Pontesilli, and F. Aiuti, Spectrotype of anti-gp120 antibodies remains stable during the course of HIV disease, J. Acquir. Immune Defic. Syndr., 5: 930-935, 1992.
7. P. Nara, M. Merges, R. Garrity, S. Con, A. Minassian, W.P. Tsai, G. Rimmelswaan, J. Goudsmit, S. Müller, H.T. Wang, and H. Köhler, Modern Approaches to New Vaccines. Cold Spring Harbar, Ny: Cold Spring Harbor Laboratory Press, 1993, Vaccine 93, pp. 167-175.
8. H. Köhler, J. Goudsmit, and P. Nara, Clonal dominance: Cause of a limited and failing immune response to HIV-1 infection and vaccination, J. AIDS, 5: 1158-1168, 1992.
9. H. Köhler, P.L. Nara, and S. Müller, Deceptive imprinting in the immune response against HIV-1, Immunol. Today, 15: 475-478, 1994.
10. P.L. Nara, and R. Garrity, Deceptive Imprinting: A cosmopolitan strategy for complicating vaccination, Vaccine, 16: 1780-1787, 1998.
11. H. Kohler, S. Muller, and P.L. Nara, Why AIDS vaccines that induce humoral immunity may not work. The Immunologist, 3: 32-34, 1995.
12. A.J. McMichaels and R.E. Philips, Escape of human immunodeficiency virus from immune control. Ann. Rev. Immunol., 15: 271-296, 1997.
13. Z.W. Chen, Y. Shen, Z. Kou, C. Ibegbu, D. Zhou, L. Shen, P. Morrison, C. Bogle, H.M. McClure, A.J. Nahmias, P.K. Sehgal, and N.L. Letvin, Prolonged dominance of restricted CD4(+) T cells in macaques infected with simian immunodeficiency virus, J. Virol., 74: 7442-7450, 2000.
14. L. Berberian, L. Goodglick, T.J. Kipps, and J.A. Braun, Immunoglobulin VH3 gene products; Natural ligands for HIV gp20, J. Science, 261: 1588-1591, 1993.
15. L. Berberian, J. Shukla, R. Jefferis, and J. Braun, Effects of HIV Infection on VH3 (D12 Idiotope) B Cells In Vivo, J. AIDS, 7: 641-646, 1994.
16. S. Muller, H.-T. Wang, S.-V. Kaveri, S. Chattopadhyay, and H. Kohler, Generation and specificity of monoclonal anti-idiotypic antibodies against human HIV-1 specific antibodies, J. Immunol., 147: 933-941, 1991.
17. H.T. Wang, S. Muller, S. Zolla-Pazner, and H. Kohler, Human monoclonal and polyclonal anti-human immunodeficiency virus-1 antibodies share a common clonotypic specificity, Eur. J. Immunol., 22: 1749-1755, 1992.
18. S. Muller and H. Kohler, B cell superantigens in HIV-1 infection, Intern. Rev. Immunol., 14: 339-349, 1997.
19. V. Veljkovic, R. Metlas, H. Kohler, et al., AIDS epidemic at the beginning of the new millenium: Time for a new AIDS strategy, JVAC, 19: 1855-1862, 2001.
20. C.P. Locher, R.M. Grant, E.A. Collisson, G. Reyes-Teran, T. Elbeik, J.O. Kahn, and J.A. Levy, Antibody and cellular immune responses in breakthrough infection subjects after HIV type 1 glycoprotein 120 vaccination, AIDS Res. Hum. Retrovir., 71: 1685-1659, 1999.
21. L. Berberian, Y. Valles-Ayoub, N. Sun, O. Martinez-Maza, and J. Braun, A VH clonal deficit in human immunodeficiency virus-positive individuals reflect a B-cell maturational arrest, Blood, 78: 175-179, 1991.
22. M. Saitta, A. Iavarone, N. Cappello, M.R. Bergami, G.C. Fiorucci, and F. Aguzzi, Reference alues for immunoglobulin kappa and lambda light-chains and the kappa/lambda ratio in children's serum, Clin. Clem., 38(12): 2454-2457, 1992.
23. A.H. Lucas, F.H. Azmi, C.M. Mink, and D.M. Granoff, Age-dependent V region expression in the human antibody response to the Haemophilus influenzae type b polysaccharide, J. Immunol., 150: 2056-2061, 1993.
24. Q. Wang, P.-A. Tovo, H. Kohler, S. Pahwa, and S. Muller, Restriction of clonal heterogeineity and maternal imprinting of B cells in the baby's immune response against HIV-1. Abstract 1209. Human immunodeficiency virus and animal model, FASEB J. Abstracts, part I, Experimental Biology Meeting, Atlanta, GA 9-13, April 1995.
25. Center for Disease Control(CDC), Revised classification system for human immunodeficiency virus infection in children less than 13 years of age, MMWK, 43: 1-10, 1994.
26. M. Saitta, F. Gaido, E. Palombo, P. Cirino, A. Giaccone, E. Ciuti, and P.A. Tovo, Reduced immunoglobulin Kappa/lambda light chain ratio in perinatally HIV-1 infected children, Fed. AIDS HIV Infect., Fetus to Adolescent, 5: 344-349, 1994.
27. Y.J. Bryson, S. Pang, L.S. Wei, R. Dickover, A. Diagne, and I.S.Y. Chen, Clearance of HIV Infection in a Perinatally Infected Infant, New Eng. J. Med., 332(13): 833-838, 1995.
28. H. Pollack, M.X. Zhan, T. Ilmet-Moore, K. Ajuang-Siimbiri, K. Krasinski, and W. Borkowsky, Ontogeny of anti-human Immunodeficiency virus (HIV) antibody production in HIV-1-infected infants, Proc. Nat. Acad. Sci., 90: 2340-2344, 1993.
29. M. Wikler, C. Demeur, G. Dewasme, and J. Urbain, Immunoregulatory role of matrnal idiotopes. Ontogeny of immune networks, J. Exp. Med., 152: 1024-1035, 1980.
30. J. Salk, P.A. Bretscher, P.L. Salk, M. Clerici, and G.M. Shearer, Strategy for Prophylactic Vaccination against HIV, Science, 260: 1270-1272, 1993.
31. D.H. Barouch, S. Santra, J.E. Schmitz, M.J. Kuroda, T.-M. Fu, W. Wagner, M. Bilska, A. Craiu, X.X. Zheng, G.R. Krivulka, K. Beaudry, M.A. Lifton, C.E. Nickerson, W.L. Trigona, K. Punt, D.C. Freed, L. Guan, S. Dubey, D. Casimiro, W.P. Tsai, G. Lin, J. J. de Jong, J. Goudsmit, M. Chastain, T.B. Strom, R.S. Gelman, P.L. Nana, A. Simon, M.-E. Davies, D.C. Montefiori, M.G. Lewis, E.A. Emini, J.W. Shiver, and N.L. Letvin. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination, Science, 290: 486-492, 2000.
32. H. Kohler, Superantibodies. Synergy of Innate and Aquired Immunity, Appln. Biochem. Biotechnol., 83: 1-12, 2000.
33. R.R. Garrity, G. Rimmelzwaan, A. Minassian, Refocusing neutralizing antibody response by targeted dampening of an immunodomiant epitope, J. Immunol., 159: 279-289, 1997.
34. M. Agadjananyan, L.M.A. Ping, J. Westerink, and T. Kicbert-Emmous. Peptide mimicry of carbohydrate epitopes on human immunodeficiency virus, Nature Biotechnol., 15: 547-551, 1997.
35. J.A. Levy, What can be achieved with an HIV vaccine? Lancet, 357: 223-224, 2001.
36. J.F. Zagury, A. Sill, W. Blattner, et al., Antibodies to HIV-1 tat protein correlated with nonprogression to AIDS: A rationale for the use of tat toxoid as an HIV-1 vaccine, J. Hum. Virol., 1: 282-292, 1998.
37. C.D. Pauza, P. Trivedi, M. Wallace, et al., Vaccination with tat toxoid attenuates disease in simian/HIV-challenged macaques, Proc. Nat. Acad. Sci. USA, 97: 3515-3519, 2000.
38. A. Gringeri, E. Santagostino, M. Muca-Perja, et al., Safety and immunogenicity of HIV-1 tat toxoid in immunocompromised HIV-infected patients, J. Hum. Virol., 1: 293-298, 1998.
39. H. Kohler, M. Bhattacharya-Chatterjee, S. Muller, and K. Foon, Idiotype manipulation in disease management. In: Immunobiology of Proteins and Peptides VIII, M.Z. Atassi and G.S. Bixler, Jr., (Ed.), New York: Plenum Press, 1995, pp. 117-122.
40. S. Muller, D.H. Margolin, P.L. Nara, W.G. Alvord, and H. Kohler, Stimulation of HTV-1-neutralizing antibodies in simian HIV-IIIB-infected macaques, Proc. Nat. Acad. Sci. USA, 95: 276-281, 1998.
41. C.Y. Wang, L.S.W. Swayer, K.K. Murthy, et al., Postexposure immunoprophylaxis of primary isolates by an antibody to HIV receptor complex, Proc. Nat. Acad. Sci. USA, 96: 10367-10372, 1999.
42. T.C. Chan, G.R. Dreesman, and R.C. Kennedy, Monoclonal anti-idiotypic antibody mimics the CD4 receptor and binds human immunodeficiency virus, Proc. Nat. Acad. Sci. USA, 84: 3891-3895, 1987.
43. E.M. Zhou, T.C. Chanh, G.R. Dreesman, P. Kanda, and R.C. Kennedy, Immune response to human immunodeficiency virus. In vivo administration of anti-idiotype induced an anti-gp160 response specific for a synthetic peptide, J. Immunol., 139: 2959-2966, 1987.
44. A.G. Dagleish, B.J. Thomson, T.C. Chanh, M. Malkovsky, and R.C. Kennedy, Neutralization of HIV isolates by anti-idiotypic antibodies which mimic the T4 (CD4) epitope: A potential AIDS vaccine, Lancet, 2: 1047-1050, 1987.
45. R. Attanasio, R.C. Kennedy, J.S. Allan, V.C. Maino, and P. Kanda, Anti-idiotypic antibodies of a predefined specificity generated against CDR3VH synthetic peptides define a private anti-CD4 idiotype, Mol. Immunol., 6: 513-522, 1990.
46. R. Attanasio, J.S. Allan, S.A. Anderson, T.C. Chanh, and R.C. Kennedy, Anti-idiotype antibody response to monoclonal anti-CD4 preparations in non human primates, J. Immunol., 146: 507-514, 1991.
47. M.H. Shearer, D.K. Timanus, P.A. Benton, D.R. Lee, and R.C. Kennedy, Crossclade inhibition of human immunodeficiency virus type 1 primary isolates by monoclonal anti-CD4, J. Infec. Dis., 177: 1727-1729, 1998.
48. M.H. Shearer, A.G. Dalgleish, T.C. Chanh, and R.C. Kennedy, Idiotype cascade associated with the CD4-HIV glycoprotein 120 interaction: Immunization with anti-idiotypic antibodies induces anti-anti-idiotypic responses with anti-CD4 specificity and in vitro neutralizing activity, AIDS Res. Hum. Retrovir., 16: 77-86, 2000.
49. E.M. Zhou, K.L. Lohman, and R.C. Kennedy, Administration of noninternal image monoclonal anti-idiotypic induces idiotype restricted responses specific for human immunodeficiency virus envelope glycoprotein epitopes, Virology, 174: 9-17, 1990.
50. K.L. Lohman, M.A. Carillo, and R.C. Kennedy, Sequence analysis of the variable region of a mouse gene encoding a monoclonal anti-idiotypic antibody that detects a restricted idiotype on anti-HIV-1 gp160, Gene, 105: 283-284, 1991.
51. C.Y. Kang, P. Nara, S. Chamat, V. Caralli, A. Chen, M.L. Nguyen, H. Yoshiyama, W.J.W. Morrow, D.D. Ho, and H. Kohler, Anti-idiotype monoclonal antibody elicits broadly neutralizing anti-gp120 antibodies in monkeys, Proc. Nat. Acad. Sci. USA, 89: 2546-2550, 1992.
52. S. Kaveri, T. Kieber-Emmons, W.J.W. Morrow, S. Muller, and S. Raychaudhuri, H. Kohler, Idiotypic networks and nature of molecular mimicry: An overview, In: Methods in Enzymology; vol. 178, Antibodies, Antigens, and Molecular Mimicry, John J. Langone, (Ed.), Academic Press, San Diego, CA, 1989, pp. 3-35, Chap. 1.
53. H. Zaghouani, S.A. Andersen, K.E. Sperber, C. Daian, R.C. Kennedy, L. Mayer, C.A. Bona, Induction of antibodies to the human immunodeficiency virus type1 by immunization of baboons with immunoglobulin molecules carrying the principal neutralizing determinant. Proc. Nat. Acad. Sci. USA, 92: 631-635, 1995.